Peer-reviewedCC BYFrontiers in medicine
Stratified by baseline corticosteroid use: which advanced therapy works best for whom in ulcerative colitis?
- 1Department of Proctology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine , ,
Related
- Prior Ustekinumab Exposure and Ulcerative Colitis Are Associated with Suboptimal Trough Levels in Patients Receiving Advanced-Line Vedolizumab or Ustekinumab for Inflammatory Bowel Disease: A Cross-Sectional Cohort Study
- Is It Safe to Reduce Inhaled Corticosteroid Dose in Severe Asthma Patients Receiving Biologic Therapy?
- Exploratory baseline mucosal transcriptomics and vedolizumab response in ulcerative colitis
- Predictors of Response to Corticosteroid Therapy in Idiopathic Granulomatous Mastitis: A Retrospective Cohort Study of 176 Patients
- Risk Stratification Based on Endoscopic Ulcerative Findings in Patients with Endoscopic Non-Complete Response after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
BibTeX
@article{dong2026stratified,
title = {{Stratified by baseline corticosteroid use: which advanced therapy works best for whom in ulcerative colitis?}},
author = {Mengqing Dong and Zhicheng Li and Hongwei Hua and Qinghan Ma and Xingli Xu and Jiong Wu},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13658562},
note = {CC BY},
}
RIS
TY - JOUR
TI - Stratified by baseline corticosteroid use: which advanced therapy works best for whom in ulcerative colitis?
AU - Mengqing Dong
AU - Zhicheng Li
AU - Hongwei Hua
AU - Qinghan Ma
AU - Xingli Xu
AU - Jiong Wu
PY - 2026
DA - 2026/10/16
JO - Frontiers in medicine
UR - https://europepmc.org/article/PMC/PMC13658562
SN - 2296-858X
ER -